Filing Details
- Accession Number:
- 0000899243-21-016790
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-22 19:07:12
- Reporting Period:
- 2021-04-20
- Accepted Time:
- 2021-04-22 19:07:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1719395 | Eargo Inc. | EAR | () | P7 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1420106 | B.v. Holding Healthcare Gilde | C/O Gilde Healthcare Partners 222 Third Street, Suite 1321 Cambridge MA 02142 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-04-20 | 6,134 | $48.04 | 3,912,557 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2021-04-21 | 7,666 | $47.97 | 3,904,891 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2021-04-22 | 78,402 | $48.37 | 3,826,489 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2021-04-22 | 6,672 | $49.01 | 3,819,817 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.95 to $48.20, inclusive. The Reporting Persons undertake to provide to Eargo, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- These shares are held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde is managed by Gilde Healthcare V Management B.V. ("Management"). Management is owned by Gilde Healthcare Holding B.V. ("Holding"). Each of Management and Holding may be deemed to have voting, investment and dispositive power with respect to the securities held by Gilde. Each of Management and Holding disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of their respective pecuniary interests therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.95 to $48.01, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $47.95 to $48.94, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $48.95 to $49.10, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.